机译:Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
KU Leuven,Katholieke Univ Leuven;
Med Oncol Dept,Ctr Leon Berard;
Gynecol Oncol Unit,Univ Cattolica Sacro CuoreFac Med 1,Charles Univ PragueVall dHebron Barcelona Hosp Campus,Hosp Univ Vall dHebron;
Recurrent cervical cancer; advanced metastatic cervical cancer; investigational drugs; immunotherapy; antibody-drug conjugate; tyrosine kinase inhibitor; combination therapy; PREVIOUSLY TREATED RECURRENT; SQUAMOUS-CELL CARCINOMA; PHASE-II TRIAL; SINGLE-ARM; OPEN-LABEL; TISOTUMAB VEDOTIN; PLUS CARBOPLATIN; PD-L1 EXPRESSION; PACLITAXEL; EFFICACY;